# CMIP

## Overview
The CMIP gene encodes the c-Maf inducing protein, a multifunctional protein involved in various cellular processes, particularly in immune regulation and cytoskeletal dynamics. This protein is characterized by its complex structure, which includes domains such as the pleckstrin homology (PH) domain, leucine-rich repeat (LRR) domain, and several interacting docking sites, including a 14-3-3 module and protein kinase C (PKC) domain (Oniszczuk2019CMIP; Kamal2009Cmip). CMIP functions primarily as a negative regulator of T cell signaling by modulating the activity of Src family kinases, thereby influencing T cell receptor signaling and immune responses (Oniszczuk2019CMIP). Additionally, CMIP is implicated in various pathological conditions, including nephrotic syndrome and several cancers, where it is often overexpressed and contributes to disease progression (Ollero2021The; Zhang2010cmip). Its role in these diseases underscores its potential as a therapeutic target and biomarker for clinical applications.

## Structure
The CMIP (c-Maf inducing protein) gene encodes an 86-kDa protein with a complex molecular structure characterized by several distinct domains. The N-terminal region of CMIP contains a pleckstrin homology (PH) domain, which is often involved in membrane-associated processes (Oniszczuk2019CMIP; Kamal2009Cmip). The middle region features several interacting docking sites, including a 14-3-3 module, a protein kinase C (PKC) domain, and an extracellular signal-regulated kinase (ERK) domain. It also includes an SH3 domain similar to the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI3K) (Oniszczuk2019CMIP; Kamal2009Cmip). The C-terminal region contains a leucine-rich repeat (LRR) domain, which is typically involved in protein-protein interactions (Oniszczuk2019CMIP; Kamal2009Cmip).

CMIP is known to have splice variant isoforms, including a truncated form known as Tc-mip, which lacks the NH2-terminal PH domain. This variant is selectively expressed in certain tissues and conditions, such as the thymus and fetal liver (Grimbert2003Truncation). The protein's expression and function are regulated by transcription factors like NF-kB and WT1, and it can move between the cytoplasm, plasma membrane, and nuclear compartment (Oniszczuk2019CMIP).

## Function
The CMIP (c-Maf inducing protein) gene encodes a protein that functions as a negative regulator of T cell signaling. In healthy human cells, CMIP is involved in modulating early T cell activation by inhibiting the activation of Src family kinases, such as Lck and Fyn, which are crucial for T cell receptor signaling. This inhibition affects the recruitment and activation of these kinases, leading to a decrease in active forms and disrupting lipid raft dynamics, which are essential for the formation of the immunological synapse (Oniszczuk2019CMIP).

CMIP also interacts with proteins like Fyn and filamin A, potentially influencing cytoskeletal dynamics and impacting cytokine production, kinase activation, and membrane raft dynamics (Oniszczuk2019CMIP). It contains pleckstrin homology (PH) and leucine-rich repeat (LRR) domains, which facilitate its interactions with multiple partners, affecting cytoskeletal dynamics and downregulating NF-kB activity (Oniszczuk2019CMIP).

In the context of T cell activation, CMIP expression is associated with a decrease in IL-2 production, which is crucial for T cell proliferation and differentiation. This suggests that CMIP plays a role in maintaining peripheral tolerance and preventing excessive immune responses (Oniszczuk2019CMIP).

## Clinical Significance
The CMIP gene is implicated in various diseases and conditions through mutations, changes in expression levels, or alterations in its interactions. In nephrotic syndrome, CMIP is overexpressed in podocytes, leading to proteinuria and podocyte foot process effacement. This overexpression disrupts signaling pathways by binding to Fyn, preventing nephrin phosphorylation, and causing cytoskeletal disorganization (Zhang2010cmip). CMIP's role in nephrotic syndrome is further supported by studies showing that silencing CMIP with RNA interference can prevent proteinuria in mouse models (Zhang2010cmip).

CMIP is also associated with various cancers, including Hodgkin lymphoma, small cell lung carcinoma, gastric cancer, glioma, melanoma, choriocarcinoma, and colorectal cancer. It is considered oncogenic and a prognostic biomarker in breast cancer (Ollero2021The). In cancer cells, CMIP expression correlates with increased cell proliferation and low relapse-free survival, suggesting its role in tumor progression (Ollero2021The).

In autoimmune conditions, CMIP is suggested as an autoantigen, and genetic variants are linked to type 2 diabetes, β-cell function, and fasting plasma glucose levels (Ollero2021The). CMIP's involvement in these diseases highlights its clinical significance and potential as a therapeutic target.

## Interactions
CMIP (c-Maf inducing protein) is involved in several protein interactions that influence various cellular processes. It physically interacts with RelA, a component of the NF-kappa B (NF-κB) complex, inhibiting NF-κB activity by stabilizing I-κBα and preventing its degradation, which in turn inhibits the nuclear translocation of RelA (Kamal2009Cmip). CMIP also interacts with the Src kinase Fyn, affecting the phosphorylation of nephrin and the recruitment of N-WASP and Nck, leading to cytoskeletal disorganization in podocytes (Zhang2010cmip; Moktefi2016Repression).

In addition to these interactions, CMIP binds to the p85 regulatory subunit of phosphoinositide-3 kinase (PI3K) and filamin A, a cytoskeletal protein, suggesting a role in cytoskeletal regulation and signaling pathways (Ollero2021The). CMIP's interaction with neuronal Wiskott-Aldrich syndrome protein (N-WASP) inhibits its activation, impacting cytoskeleton regulation and promoting apoptosis (Ory2012cmip). These interactions highlight CMIP's multifunctional role in cellular signaling and its potential impact on cell fate and disease pathogenesis.


## References


[1. (Zhang2010cmip) Shao-yu Zhang, Maud Kamal, Karine Dahan, André Pawlak, Virginie Ory, Dominique Desvaux, Vincent Audard, Marina Candelier, Fatima BenMohamed, Marie Matignon, Christo Christov, Xavier Decrouy, Veronique Bernard, Gilles Mangiapan, Philippe Lang, Georges Guellaën, Pierre Ronco, and Djillali Sahali. C-mip impairs podocyte proximal signaling and induces heavy proteinuria. Science Signaling, May 2010. URL: http://dx.doi.org/10.1126/scisignal.2000678, doi:10.1126/scisignal.2000678. This article has 79 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1126/scisignal.2000678)

[2. (Oniszczuk2019CMIP) Julie Oniszczuk, Kelhia Sendeyo, Cerina Chhuon, Berkan Savas, Etienne Cogné, Pauline Vachin, Carole Henique, Ida Chiara Guerrera, Giuseppe Astarita, Vincent Frontera, Andre Pawlak, Vincent Audard, Dil Sahali, and Mario Ollero. Cmip is a negative regulator of t cell signaling. Cellular &amp; Molecular Immunology, 17(10):1026–1041, August 2019. URL: http://dx.doi.org/10.1038/s41423-019-0266-5, doi:10.1038/s41423-019-0266-5. This article has 15 citations.](https://doi.org/10.1038/s41423-019-0266-5)

[3. (Kamal2009Cmip) Maud Kamal, Asta Valanciute, Karine Dahan, Virginie Ory, Andre Pawlak, P. Lang, Georges Guellaen, and Djillali Sahali. C-mip interacts physically with rela and inhibits nuclear factor kappa b activity. Molecular Immunology, 46(5):991–998, February 2009. URL: http://dx.doi.org/10.1016/j.molimm.2008.09.034, doi:10.1016/j.molimm.2008.09.034. This article has 29 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.molimm.2008.09.034)

[4. (Ollero2021The) Mario Ollero and Dil Sahali. The enigmatic emerging role of the c-maf inducing protein in cancer. Diagnostics, 11(4):666, April 2021. URL: http://dx.doi.org/10.3390/diagnostics11040666, doi:10.3390/diagnostics11040666. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/diagnostics11040666)

[5. (Ory2012cmip) Virginie Ory, Qingfeng Fan, Nabila Hamdaoui, Shao-yu Zhang, Dominique Desvaux, Vincent Audard, Marina Candelier, Laure-Helene Noel, Philippe Lang, Georges Guellaën, Andre Pawlak, and Djillali Sahali. C-mip down-regulates nf-κb activity and promotes apoptosis in podocytes. The American Journal of Pathology, 180(6):2284–2292, June 2012. URL: http://dx.doi.org/10.1016/j.ajpath.2012.02.008, doi:10.1016/j.ajpath.2012.02.008. This article has 24 citations.](https://doi.org/10.1016/j.ajpath.2012.02.008)

[6. (Grimbert2003Truncation) Philippe Grimbert, Asta Valanciute, Vincent Audard, André Pawlak, Sabine Le gouvelo, Philippe Lang, Patrick Niaudet, Albert Bensman, Georges Guellaën, and Djillali Sahali. Truncation of c-mip (tc-mip), a new proximal signaling protein, induces c-maf th2 transcription factor and cytoskeleton reorganization. The Journal of Experimental Medicine, 198(5):797–807, August 2003. URL: http://dx.doi.org/10.1084/jem.20030566, doi:10.1084/jem.20030566. This article has 66 citations.](https://doi.org/10.1084/jem.20030566)

[7. (Moktefi2016Repression) Anissa Moktefi, Shao-yu Zhang, Pauline Vachin, Virginie Ory, Carole Henique, Vincent Audard, Catherine Rucker-Martin, Elodie Gouadon, Michael Eccles, Andreas Schedl, Laurence Heidet, Mario Ollero, Djillali Sahali, and Andre Pawlak. Repression of cmip transcription by wt1 is relevant to podocyte health. Kidney International, 90(6):1298–1311, December 2016. URL: http://dx.doi.org/10.1016/j.kint.2016.07.016, doi:10.1016/j.kint.2016.07.016. This article has 17 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.kint.2016.07.016)